When will Pitolisant be launched in the country? Approval time and sales progress

Pitolisant (Pitolisant) is an oral histamine H3 receptor antagonist/inverse agonist, mainly used to treat patients with narcolepsy to improve excessive daytime sleepiness and related cognitive dysfunction. According to domestic drug approval information, the original drug of tilorisen has obtained marketing approval in China and is included in the scope of medical insurance, providing patients with accessible treatment options. The domestic launch of this drug marks the further improvement of the field of professional drug treatment for narcolepsy, and also meets the urgent clinical demand for targeted therapeutic drugs.

The size of tilorisen available in China is 4.5mg*30 tablets, and the price per box is about 1,000 yuan. Since it has been included in medical insurance, patients can enjoy reimbursement according to local medical insurance policies, reducing the financial burden of medication. This provides a more stable channel for narcolepsy patients who have been taking medication for a long time to obtain drugs, and at the same time helps improve patient compliance and treatment continuity. Clinically, the dose of the drug can be adjusted according to the patient's weight, symptom severity and tolerance, and is usually gradually increased to the optimal dose under the guidance of a doctor.

In overseas markets, tilorisen is also available as original drug and generic drug. Overseas generic drugs, such as those produced by Lao pharmaceutical factories, are 18mg*30 tablets. Each box sells for about 3,000 yuan. The ingredients of the drug are basically the same as the original drug, and the efficacy and safety have been verified. For domestic patients, some overseas drugs can be obtained through formal overseas channels, but they must follow local regulations and medical instructions to ensure drug safety.

Overall, the domestic launch of tilorisen not only broadens the treatment options for narcolepsy patients, but also provides patients with an affordable long-term medication plan. With the accumulation of clinical experience and the implementation of medical insurance policies, patients can safely and standardly use tilorisen for symptom management under the guidance of doctors, thereby improving their quality of life. The differences between domestic and foreign drugs are mainly in specifications and prices, but the active ingredients are basically the same, providing patients with diversified ways to obtain them.

Keyword tag:

Pitolisant, narcolepsy, domestic launch, approval time, medical insurance, price, specifications, overseas generic drugs

Reference materials:https://en.wikipedia.org/wiki/Pitolisant